31 min
Benjamin-Alexandre Jeanroy, Co-Founder & CEO at Augur Associates Professionally Cannabis & Psychedelics
-
- Health & Fitness
Earlier this year, we discussed everything French Cannabis with Benjamin-Alexandre Jeanroy, the Co-Founder & CEO of Augur Associates.
The long-awaited two year ‘cannabis experiment’ in France was given the green light in March, providing access to medical cannabis and cannabis medicines for approximately 3000 patients. Benjamin talks through how this will work in practice, the way in which patients will be able to access medicine, the companies that are supplying the product, and the socio-political status of cannabis in France – one of the largest consumers of the plant in Europe.
Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content at: https://contenthub.gcintelligence.com/
Earlier this year, we discussed everything French Cannabis with Benjamin-Alexandre Jeanroy, the Co-Founder & CEO of Augur Associates.
The long-awaited two year ‘cannabis experiment’ in France was given the green light in March, providing access to medical cannabis and cannabis medicines for approximately 3000 patients. Benjamin talks through how this will work in practice, the way in which patients will be able to access medicine, the companies that are supplying the product, and the socio-political status of cannabis in France – one of the largest consumers of the plant in Europe.
Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content at: https://contenthub.gcintelligence.com/
31 min